Congressional Quarterly reports an 18% reduction in opioid use among Medicare patients in recent years1. This is certainly movement in the right direction – especially considering prescriptions to this population have long been considered a source of diverted opioids. The Medicare Payment Advisory Commission is expected in March to recommend additional monitoring and tracking of […]
Companies seek to shift the tide in the battle against Opioid addition by merging HSR’s AI-tech with myMAR’s caregiver-focused online portal. The Opioid epidemic is ravaging our country, hitting our nation so hard, that it alone has lowered life expectancy in the United States. Only recently has it started to gain the attention it deserves. […]
Purdue Pharma LP has announced an end to its practice of pressuring physicians to write prescriptions of OxyContin – a market leading opioid pain killer. Purdue’s move, as reported in Friday’s Wall Street Journal article, “Purdue Pharma to Stop Promoting OxyContin to U.S. Doctors” by Jeanne Whalen, is further evidence that efforts to raise awareness […]
Fight Fire with Fire is certainly and age-old adage. And Philadelphia’s plan to open up
Webster’s dictionary defines Epidemic as “a sudden, widespread occurrence of a particular undesirable phenomenon.” That is exactly what the we are experiencing with opioids. HSR has taken on this battle in many ways and now we have launched a grassroots campaign to talk about the opioid epidemic. In our messaging not only do we share […]
HSR CMO Ram Peruvemba, MD, a board-certified Anesthesiologist and Pain Management physician, is serving as a Maryland Delegate to the Annual Meeting of the American Society of Anesthesiologists (ASA) currently taking place at the Boston Convention and Exhibition Center in Boston, Massachusetts. The Annual Meeting began on Saturday, October 21st and runs until this Wednesday, October […]
Last week, CVS Health announced it will limit the duration and dosage of opioid pain killers to certain individuals. HSR commends CVS Health for taking action towards addressing the Opioid Crisis in the United States. However, we caution that simply limiting access to Opioids or the dosage of certain painkillers, while certainly well-intentioned, may wind […]
We are proud to introduce John Zaleski, PhD, CAP, CPHIMS, Chief Analytics Officer of Bernoulli Enterprise, Inc., as the newest member of Health Solutions Research, Inc.’s Board of Advisors! John’s Role on HSR’s Board HSR has come a long way in our slightly over 2 years in operation. In fact, with our proprietary Geospatial data […]